Intuitive Surgical Inc. (NASDAQ:ISRG) had its price objective raised by equities researchers at Royal Bank Of Canada from $750.00 to $760.00 in a report released on Wednesday. The firm presently has a “sector perform” rating on the stock. Royal Bank Of Canada’s target price indicates a potential upside of 5.30% from the stock’s previous close.

A number of other equities analysts also recently commented on ISRG. Zacks Investment Research downgraded Intuitive Surgical from a “hold” rating to a “sell” rating in a research note on Tuesday, June 21st. Bank of America Corp. reiterated a “buy” rating on shares of Intuitive Surgical in a research note on Wednesday, June 22nd. Stifel Nicolaus raised their target price on shares of Intuitive Surgical from $700.00 to $800.00 and gave the stock a “buy” rating in a report on Wednesday, July 20th. Wedbush raised their target price on shares of Intuitive Surgical from $715.00 to $755.00 and gave the stock an “outperform” rating in a report on Wednesday, July 20th. Finally, Canaccord Genuity raised their target price on shares of Intuitive Surgical from $700.00 to $750.00 and gave the stock a “buy” rating in a report on Wednesday, July 20th. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and fourteen have assigned a buy rating to the company. The company has a consensus rating of “Buy” and an average price target of $710.82.

Analyst Recommendations for Intuitive Surgical (NASDAQ:ISRG)

Shares of Intuitive Surgical (NASDAQ:ISRG) opened at 721.73 on Wednesday. The firm has a market cap of $27.78 billion, a PE ratio of 40.96 and a beta of 0.72. Intuitive Surgical has a 12-month low of $483.11 and a 12-month high of $727.25. The company has a 50 day moving average price of $703.09 and a 200-day moving average price of $666.36.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, October 18th. The company reported $6.19 EPS for the quarter, topping the Zacks’ consensus estimate of $5.13 by $1.06. The business earned $682.90 million during the quarter, compared to the consensus estimate of $650.49 million. Intuitive Surgical had a return on equity of 15.25% and a net margin of 26.80%. The company’s revenue for the quarter was up 15.8% compared to the same quarter last year. During the same period last year, the firm earned $5.24 earnings per share. Analysts expect that Intuitive Surgical will post $21.30 EPS for the current year.

In other Intuitive Surgical news, SVP Mark J. Meltzer sold 3,000 shares of Intuitive Surgical stock in a transaction that occurred on Monday, August 22nd. The shares were sold at an average price of $688.33, for a total value of $2,064,990.00. Following the transaction, the senior vice president now owns 2,331 shares in the company, valued at $1,604,497.23. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, SVP Curet Myriam sold 4,250 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, July 27th. The stock was sold at an average price of $684.39, for a total transaction of $2,908,657.50. Following the completion of the transaction, the senior vice president now owns 3,133 shares in the company, valued at approximately $2,144,193.87. The disclosure for this sale can be found here. 3.10% of the stock is currently owned by company insiders.

A number of hedge funds and other institutional investors have recently bought and sold shares of ISRG. Vanguard Group Inc. boosted its position in Intuitive Surgical by 3.4% in the second quarter. Vanguard Group Inc. now owns 2,326,605 shares of the company’s stock valued at $1,538,841,000 after buying an additional 77,521 shares during the last quarter. FMR LLC boosted its position in Intuitive Surgical by 15.5% in the second quarter. FMR LLC now owns 2,190,718 shares of the company’s stock valued at $1,448,962,000 after buying an additional 294,511 shares during the last quarter. BlackRock Institutional Trust Company N.A. boosted its position in Intuitive Surgical by 3.1% in the second quarter. BlackRock Institutional Trust Company N.A. now owns 989,902 shares of the company’s stock valued at $654,731,000 after buying an additional 29,881 shares during the last quarter. BlackRock Fund Advisors boosted its position in Intuitive Surgical by 24.3% in the second quarter. BlackRock Fund Advisors now owns 831,970 shares of the company’s stock valued at $550,273,000 after buying an additional 162,789 shares during the last quarter. Finally, JPMorgan Chase & Co. boosted its position in Intuitive Surgical by 87.7% in the second quarter. JPMorgan Chase & Co. now owns 619,160 shares of the company’s stock valued at $409,519,000 after buying an additional 289,330 shares during the last quarter. Hedge funds and other institutional investors own 92.03% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

5 Day Chart for NASDAQ:ISRG

Receive News & Stock Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related stocks with our FREE daily email newsletter.